Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

CRISPR Therapeutics AG (CRSP)

38.83   -0.61 (-1.55%) 05-17 16:00
Open: 38.95 Pre. Close: 39.44
High: 39.36 Low: 38.2475
Volume: 296,821 Market Cap: 2053M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 39.402 - 39.628 39.628 - 39.832
Low: 37.735 - 37.979 37.979 - 38.199
Close: 38.475 - 38.871 38.871 - 39.227

Technical analysis

as of: 2019-05-17 4:27:37 PM
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 46.72     One year: 50.22
Support: Support1: 35.15    Support2: 29.24
Resistance: Resistance1: 40.00    Resistance2: 43.00
Pivot: 39.61
Moving Average: MA(5): 38.46     MA(20): 39.46
MA(100): 35.58     MA(250): 43.13
MACD: MACD(12,26): 0.26     Signal(9): 0.49
Stochastic oscillator: %K(14,3): 31.63     %D(3): 24.15
RSI: RSI(14): 49.87
52-week: High: 73.90  Low: 22.22  Change(%): -40.0
Average Vol(K): 3-Month: 70239  10-Days: 44353

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
CRSP has closed above bottom band by 32.8%. Bollinger Bands are 45.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to CRSP's normal range. The bands have been in this narrow range for 5 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Mon, 13 May 2019 18:06:48 Z
5 Growthy Biotech Stocks to Buy Despite the Scrutiny

Wed, 08 May 2019 14:15:01 Z
Why CRISPR Therapeutics Gained 13.4% in April

Tue, 07 May 2019 22:08:29 Z
CRSP Crosses Below Key Moving Average Level

Thu, 02 May 2019 21:09:04 Z
Vertex Pharmaceuticals Looks to Jump From 18,000 Patients to 68,000

Wed, 01 May 2019 18:12:20 Z
Vertex (VRTX) Q1 Earnings and Revenues Surpass Estimates

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 52.91
Shares Float (M) 51.08
% Held by Insiders
% Held by Institutions 52.50
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS -3.430
EPS Est. Current Year -2.430
EPS Est. Next Year -3.020
EPS Est. Next Quarter -0.740
Forward EPS -3.299
Book Value (p.s.) 5.570
PEG Ratio
Profit Margin
Operating Margin -8613.61
Return on Assets (ttm) -44.1
Return on Equity (ttm) -57.5
Qtrly Rev. Growth -75.8
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -117.29
Levered Free Cash Flow (M) -66.90

Stock Valuations

P/E -11.32
P/E Growth Ratio -0.02
P/BV 6.97
P/S 51333263360.00
P/CF -17.52

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.